Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.56 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | LTA | P01374 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.35 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.35 |
| ▸ | RAD1 | O60671 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bitoscanate SCHEMBL157128 | 0.86 | MIF (0.72) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL13881813 | 0.79 | MIF (0.56) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL7203092 | 0.78 | P2RY6 (0.68) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL1548531 | 0.78 | MIF (0.62) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL14344845 | 0.76 | MIF (0.59) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL2005750 | 0.74 | CYP3A4 (0.56) | P2RY6CA1CA2CYP3A4TDP1 | |
| SCHEMBL6815770 | 0.74 | MIF (0.56) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL457225 | 0.74 | MIF (0.56) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL9446548 | 0.74 | MIF (0.56) | MIFP2RY6CA1CA2HSD17B10 | |
| SCHEMBL331404 | 0.74 | MIF (0.56) | MIFP2RY6CA1CA2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023170174-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF AN ISOMER-FREE DIENOPHILE | UNIVERSITY OF COPENHAGEN (DK) | 2023-09-14 | — | — | WO | claimed |
| WO-2023170164-A1 | METHOD FOR PROVIDING A LABELED SINGLE ISOMERIC CHEMICAL ENTITY TARGETING VECTOR BASED ON THE USE OF A SYMMETRICAL DIENE | UNIVERSITY OF COPENHAGEN (DK) | 2023-09-14 | — | — | WO | claimed |
| US-20030198598-A1 | Polypeptide derivatives | ALBERT RAINER (CH) | 2003-10-23 | — | — | US | claimed |
| US-5686410-A | EPIDERMAL GROWTH FACTOR WITH CHELATING GROUP | NOVARTIS AG (CH) | 1997-11-11 | — | — | US | claimed |
| EP-0484989-B1 | Polysubstituted diethylenetriamine chelates for forming a metal-chelate-protein conjugate | GANSOW OTTO A (US) | 1996-04-24 | — | — | EP | claimed |
| EP-0484989-A1 | Polysubstituted diethylenetriamine chelates for forming a metal-chelate-protein conjugate | GANSOW, Otto A. (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0436005-A1 | LABELED POLYPEPTIDE DERIVATIVES. | SANDOZ LTD (CH) | 1991-07-10 | — | — | EP | claimed |
| EP-0328529-A4 | BACKBONE POLYSUBSTITUTED CHELATES FOR FORMING A METAL CHELATE-PROTEIN CONJUGATE | — | 1991-03-20 | — | — | EP | claimed |
| WO-1991001144-A1 | LABELED POLYPEPTIDE DERIVATIVES | SANDOZ LTD (CH) | 1991-02-07 | — | — | WO | claimed |
| EP-0328529-A1 | METHOD FOR PREPARING POLYSUBSTITUTED DIETHYLENETRIAMINEPENTAACETIC ACIDS. | GANSOW OTTO A (US) | 1989-08-23 | — | — | EP | claimed |
| US-4833073-A | Immunoassay for tetrahydrocannabinol metabolites | HOFFMANN-LA ROCHE INC. (US) | 1989-05-23 | — | — | US | claimed |
| WO-1988001618-A1 | BACKBONE POLYSUBSTITUTED CHELATES FOR FORMING A METAL CHELATE-PROTEIN CONJUGATE | GANSOW OTTO A (US) | 1988-03-10 | — | — | WO | claimed |
| EP-4380632-A1 | RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF CANCERS | Actinium Pharmaceuticals, Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-113993547-B | Use of bispecific antigen binding molecules binding MUC16 and CD3 in combination with 4-1BB costimulation | 瑞泽恩制药公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-114025802-B | Use of bispecific antigen binding molecules binding to PSMA and CD3 in co-stimulatory combinations with 4-1BB | 瑞泽恩制药公司 | 2024-04-23 | — | — | CN | disclosed |
| EP-4341265-A1 | TRIVALENT RADIOISOTOPE BIO-TARGETED RADIOPHARMACEUTICAL, METHODS OF PREPARATION AND USE | Northstar Medical Technologies LLC (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-1989012631-A1 | MACROCYCLIC BIFUNCTIONAL CHELANTS, COMPLEXES THEREOF AND THEIR ANTIBODY CONJUGATES | THE DOW CHEMICAL COMPANY (US) | 1989-12-28 | — | — | WO | disclosed |
| EP-0327365-A2 | Improvements in or relating to modified haptens useful as imaging and therapeutic agents | HYBRITECH INCORPORATED (US) | 1989-08-09 | — | — | EP | disclosed |
| EP-0296522-A2 | Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation | THE DOW CHEMICAL COMPANY (US) | 1988-12-28 | — | — | EP | disclosed |
| EP-0085554-A1 | Molecular analytical release tags and their use in chemical analysis | NORTHEASTERN UNIVERSITY (US) | 1983-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198598-A1 | Polypeptide derivatives | HDGF, IGFBP1, VIP | MIF 116/4885P2RY6 3261/4885CA1 1758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.